The Trevo Retriever is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Introduction
The Pipeline Embolization Device TM (PED, Covidien-Ev3, Plymouth, MN) was approved by the Food and Drug Administration (FDA) in 2011 for large or giant wide-necked intracranial aneurysms of the internal carotid artery, but numerous studies have since demonstrated safety and efficacy for various aneurysm characteristics. [1] [2] [3] [4] [5] The most recent iteration of the device is called PED Flex and adds the ability to resheath and re-position the device following partial deployment. 6 The platinum coil for braid protection located at the distal end of the PED in the original PED version was replaced by polytetrafluoroethylene (PTFE) sleeves in the PED Flex. In some cases, however, we have encountered delayed opening of the distal end of the PED, which can be hazardous if the distal landing zone is short and accurate placement is essential. In such cases we have found ex-vivo, preimplantation release of the PED PTFE sleeves to be extremely helpful. Here, we report a technique that may be advantageous in selected aneurysms.
Technical note
The technique is performed after the appropriate PED Flex size and length have been selected and the device is removed from the package. In a bowl of saline the PED is partially pushed out of the introducer sheath ex-vivo, pre-implantation until the distal PED opens entirely and the PTFE sleeves are distal to the distal device end. Without inverting the PTFE sleeves, the PED is carefully pulled back into the introducer sheath placing the PTFE sleeves inside the device (Figure 1 ). The PED is then loaded into the microcatheter and advanced toward the site of implantation. When the PED is initially deployed and pushed out of the microcatheter, it opens immediately and provides an anchor for the remainder of the deployment process.
Illustrative case
A 75-year-old white man presented with progressive signs and symptoms of brainstem compression from a large, partially thrombosed, dolichoectatic basilar trunk aneurysm. The patient had significant comorbidities including a history of abdominal aortic aneurysm rupture, coronary artery disease status post-bypass operation, and chronic kidney disease rendering him too high a risk for an open surgical operation. Given his neurologic deterioration, the decision was made to reconstruct the basilar artery using PED. The patient was started on aspirin 325 mg daily and Plavix 75 mg daily, two weeks prior to the procedure. A platelet function test obtained one week prior to the procedure confirmed adequate platelet inhibition by both medications. For the procedure a 6F Cook Shuttle (Cook, Bloomington, IN) was placed in the cervical left vertebral artery. A Navien TM intracranial support catheter was placed in the V3 segment and a Marksman TM Microcatheter (Covidien-Ev3, Plymouth, MN) was navigated over a microwire past the aneurysm into the proximal left posterior cerebral artery. The segment of basilar artery distal to the dolichoectatic segment was short, which complicated anchoring the PED distally. The posterior cerebral arteries were small and inadequate for anchoring. The potential for delayed opening of the distal end of the PED and prolapse of the PED into the aneurysm or the need to recapture the PED with the microcatheter were considered unacceptable. The PTFE sleeves were released ex-vivo, preimplantation as described above and the first PED was successfully placed with immediate and precise wall apposition. A second short PED was deployed to reinforce the distal anchor. The basilar artery was subsequently reconstructed with a total of five PEDs. The PTFE sleeves were released ex-vivo, pre-implantation in all five PEDs and delivery through the same microcatheter did not present a problem. The patient tolerated the procedure well and was discharged at his neurologic baseline two days after the procedure.
Discussion
We report a technical nuance that facilitates distal landing zone accuracy of the PED in vivo by ex-vivo, preimplantation release of the PED Flex PTFE sleeves. To our knowledge, this has not been previously reported. Thus far we have successfully used the technique in 21 aneurysms treated with 25 PEDs whenever distal landing zone accuracy was particularly critical. Examples include the case presented here, in which the posterior cerebral arteries were too small for anchoring the PED and the distal, non-diseased segment of the basilar artery was short. Other instances in which we have used this technique successfully include aneurysms of the paraophthalmic internal carotid artery where the desired landing position is short and located between the posterior communicating artery distally and the distal end of the aneurysm proximally or large and giant aneurysms where the distal landing zone was short and lack of immediate wall apposition may have resulted in prolapse of the PED into the aneurysm. In these situations we have found the ex-vivo, pre-implantation release of the PTFE sleeves a valuable technique.
Conventional deployment mechanism of Pipeline Flex
Deployment of an appropriately sized PED requires microcatheter placement distal to the aneurysm neck. The delivery system, which contains the affixed PED, is advanced through the microcatheter until the tip of the microcatheter and the guide wire are aligned. The tip of the guide wire lies 15 mm distal to a radiopaque marker followed by two PTFE sleeves and the PED. 7 Deployment of the device requires an initial phase of unsheathing followed by a phase of device pushing alternating with another phase of unsheathing to release the proximal end of the PED. Upon deployment, the device expands radially and compresses longitudinally. The microcatheter can be advanced distally to recapture the guide wire following PED placement.
Function of PTFE sleeves and nuances of the technique
Positioned adjacent to the aforementioned radiographic marker on the guide wire, the PTFE-sleeves enclose and protect the leading edge of the device and prevent its incidental expansion. If the PED is partially deployed and the distal end does not open, the manufacturer recommends recapturing the device entirely and, by doing so, inverting the PTFE sleeves. 8 The need to recapture the device, however, may not be desired when the device is otherwise well positioned and can complicate the procedure. Furthermore, inverting the PTFE sleeves in-vivo may theoretically result in the inverted PTFE sleeves getting stuck as they are pulled into the microcatheter. Inverting the PTFE sleeves in vivo has a similar effect as releasing the PTFE sleeves ex-vivo, pre-implantation. At that point, the PED will be redeployed without the protective aspect of the PTFE sleeves since they have been inverted and are now located inside the device. Invivo recapturing and redeployment has been extensively tested by the manufacturer and is considered safe. The only difference from the technique described here is that the ex-vivo, pre-implantation release results in a longer distance for the PED to travel within the microcatheter with its distal end unprotected by the PTFE sleeves. We acknowledge that the technique demonstrated here represents an off-label use and is not supported by the manufacturer. The technique has been assessed only in a clinical setting without extensive laboratory evaluation. There is a potential risk for the unprotected braids to get stuck or damaged when advanced inside the microcatheter. We, however, have not encountered situations in which the PED braids have gotten caught in the microcatheter, the PED was damaged to such a degree that it would not open properly or the inside of the microcatheter was scratched prohibiting placement of multiple PEDs. Pushing the PED through the microcatheter without the PTFE sleeves protecting its leading end has not been found to be any more difficult than with the PTFE sleeves in their original configuration. We do, however, feel that reporting this technical nuance may be of value to neurointerventionists in selected cases, even though we caution against the indiscriminate use of the technique given the potential limitations and are not advocating for the routine use in violation of the manufacturer's instruction for use.
Conclusion
Ex-vivo, pre-implantation release of the PTFE sleeves is an option in aneurysms for which distal landing accuracy is critical and immediate wall apposition desired. Even without the protection of the PTFE sleeves, our clinical observation shows that the PED can be advanced through the microcatheter safely in selected cases.
